Prostaglandin E 2 promotes the nuclear accumulation of lymphoid enhancer factor-1 in poorly differentiated breast cancer cells

Prostaglandins and Other Lipid Mediators

Volumn 99, Issue 1-2, 2012, Pages 9-14

  Stasinopoulos, Ioannis ^a   Greenwood, Tiffany ^a   Glunde, Kristine ^a,b   Bhujwalla, Zaver M ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Catenin; Breast cancer; COX 2; Cyclooxygenase 2; Inflammation; LEF 1; Lymphoid enhancer factor 1; PGE 2; Prostaglandin E 2; Wnt

Indexed keywords

BETA CATENIN; CYCLOOXYGENASE 2; LYMPHOID ENHANCER FACTOR 1; PROSTAGLANDIN E2; SHORT HAIRPIN RNA; WNT PROTEIN; CATNB PROTEIN, MOUSE; LEF1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; DOWN REGULATION; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; LIMIT OF DETECTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WNT SIGNALING PATHWAY; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; CELL DIFFERENTIATION; FEMALE; GENE SILENCING; GENETICS; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; BETA CATENIN; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; GENE SILENCING; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE;

EID: 84865519049     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2012.05.002     Document Type: Article

References (33)

1. J.S. Reis-Filho, and L. Pusztai Gene expression profiling in breast cancer: classification, prognostication, and prediction Lancet 378 9805 2011 1812 1823
2. M.J. Higgins, and J. Baselga Targeted therapies for breast cancer J Clin Invest 121 10 2011 3797 3803
3. I. Stasinopoulos Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells Mol Cancer Res 5 5 2007 435 442
4. I. Stasinopoulos, N. Mori, and Z.M. Bhujwalla The malignant phenotype of breast cancer cells is reduced by COX-2 silencing Neoplasia 10 11 2008 1163 1169
5. I. Stasinopoulos, D.R. O'Brien, and Z.M. Bhujwalla Inflammation: but not hypoxia, mediated HIF-1alpha activation depends on COX-2 Cancer Biol Ther 8 1 2009 31 35
6. X. Xie Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals Nature 434 7031 2005 338 345
7. C.A. Gebeshuber, S. Sladecek, and S. Grunert Beta-catenin/LEF-1 signalling in breast cancer - central players activated by a plethora of inputs Cells Tissues Organs 185 1-3 2007 51 60
8. L. Arce, N.N. Yokoyama, and M.L. Waterman Diversity of LEF/TCF action in development and disease Oncogene 25 57 2006 7492 7504
9. A. Ravindranath The role of LEF/TCF factors in neoplastic transformation Curr Mol Med 8 1 2008 38 50
10. P. Hatzis Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells Mol Cell Biol 28 8 2008 2732 2744
11. T.C. He Identification of c-MYC as a target of the APC pathway Science 281 5382 1998 1509 1512
12. O. Tetsu, and F. McCormick Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells Nature 398 6726 1999 422 426
13. O.J. Sansom Myc deletion rescues Apc deficiency in the small intestine Nature 446 7136 2007 676 679
14. G.S. Yochum, R. Cleland, and R.H. Goodman A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-MYC gene expression Mol Cell Biol 28 24 2008 7368 7379
15. T. Kramps Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex Cell 109 1 2002 47 60
16. B. Thompson A new nuclear component of the Wnt signalling pathway Nat Cell Biol 4 5 2002 367 373
17. K.M. Cadigan, and M. Peifer Wnt signaling from development to disease: insights from model systems Cold Spring Harb Perspect Biol 1 2 2009 a002881
18. D.L. Daniels, and W.I. Weis Beta-catenin directly displaces Groucho/TLE repressors from TCF/LEF in Wnt-mediated transcription activation Nat Struct Mol Biol 12 4 2005 364 371
19. A. Hecht The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates EMBO J 19 8 2000 1839 1850
20. A.V. Tutter, C.J. Fryer, and K.A. Jones Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro Genes Dev 15 24 2001 3342 3354
21. C. Liu Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism Cell 108 6 2002 837 847
22. H. Blaker Somatic mutations in familial adenomatous polyps. Nuclear translocation of beta-catenin requires more than biallelic APC inactivation Am J Clin Pathol 120 3 2003 418 423
23. M.D. Castellone Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis Science 310 5753 2005 1504 1510
24. A. Rostom Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force Ann Intern Med 146 5 2007 376 389
25. G. Steinbach The effect of celecoxib: a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis N Engl J Med 342 26 2000 1946 1952
26. W. Goessling Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration Cell 136 6 2009 1136 1147
27. S. Hino Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination Mol Cell Biol 25 20 2005 9063 9072
28. M.M. Mueller Inflammation in epithelial skin tumours: old stories and new ideas Eur J Cancer 42 6 2006 735 744
29. Y.M. Sung, G. He, and S.M. Fischer Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development Cancer Res 65 20 2005 9304 9311
30. A. Nguyen Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression Int J Oncol 27 4 2005 949 956
31. K. Hovanes Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer Nat Genet 28 1 2001 53 57
32. M. Planutiene, K. Planutis, and R.F. Holcombe Lymphoid enhancer-binding factor 1, a representative of vertebrate-specific LEF1/TCF1 sub-family, is a Wnt-beta-catenin pathway target gene in human endothelial cells which regulates matrix metalloproteinase-2 expression and promotes endothelial cell invasion Vasc Cell 3 2011 28
33. E. Dejana The role of Wnt signaling in physiological and pathological angiogenesis Circ Res 107 8 2010 943 952